The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.
about
Recent developments of protein kinase inhibitors as potential AD therapeuticsTargeting innate immunity for neurodegenerative disorders of the central nervous systemMetabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and TreatmentBioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionThe Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesRodent models of neuroinflammation for Alzheimer's diseaseThe role of inflammasome in Alzheimer's diseaseAlterations in immune cells and mediators in the brain: it's not always neuroinflammation!Interleukin-1β has trophic effects in microglia and its release is mediated by P2X7R pore.[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in ratsEmerging Roles for the Immune System in Traumatic Brain InjuryLessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer's DiseaseMechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid estersAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyEffects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 miceUp-regulation and activation of the P2Y(2) nucleotide receptor mediate neurite extension in IL-1β-treated mouse primary cortical neuronsPharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study.Glial contributions to neurodegeneration in tauopathies.Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease.Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.Plexin-A1 is required for Toll-like receptor-mediated microglial activation in the development of lipopolysaccharide-induced encephalopathyAssociation of IL1A and IL1B loci with primary open angle glaucoma.Combination therapy with an anti-IL-1β antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model.1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patientsMultiplexed Electrochemical Immunosensors for Clinical BiomarkersTreatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseMetabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like ratsAssociation of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibilityInflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.P2Y receptors in Alzheimer's disease.Induction of an inflammatory loop by interleukin-1β and tumor necrosis factor-α involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β.Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curliThe role of the anaphylatoxins in health and disease.The Nrf2-ARE cytoprotective pathway in astrocytes.Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell typesBrain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.
P2860
Q21129481-EAF974D3-B9A6-4A81-845F-D45CFF3610DBQ26744219-B84DE3F1-416D-4A16-8E64-57CBB10E0B56Q26799893-D1E6BFDF-4191-483F-BCF1-6A6870713725Q26822410-75192C76-A027-41EC-8366-DB5A66DD7971Q26822972-C50A29C6-8622-477B-B741-A6309FF8EEA7Q26864804-1E29515B-5C2E-44AD-AE8B-B4E595851E46Q26996822-A2B0FEC3-A957-4D0B-B670-13B62B1A79ACQ27010652-41E4C800-BCA8-4CDC-ADF5-15FCADEE6AB0Q27303076-F2BB49E4-2D2A-49DC-B04C-E2F32299EBE1Q27314677-0394A863-FFC4-432A-9C9E-45AECB2C0249Q28071271-F6C534AD-A18A-4E74-A731-F3EDD8A48B09Q28085613-763CFC1C-ED47-4E03-8A4A-1AFFA72DE2D0Q28389828-6EC64E5F-6D6C-4088-9CA0-0E5493524555Q28395248-10D82F07-C083-4084-93D3-F861529D1951Q28533783-6D77E32C-610B-4282-BDFB-E4A4A91A4A1EQ30540447-E3DDC8B6-2AFD-4E94-9231-4651AA118DE3Q31033689-6A717533-3816-41E4-B577-1971AA78E81DQ32173558-767B1F90-8DF5-439E-8E07-5F8A5AD18CC2Q33460503-A3E26C27-22C7-4595-8C9B-AAF0DD6C1C29Q33556064-0CC3C3F1-7798-455D-A09C-8CA4CC6DA6A9Q33565510-9A8C701B-8B2A-48F6-9322-40C37EAF6715Q33608671-C9FCC352-2C76-4D2F-904C-16E8F3D92804Q33611297-602E3283-2E29-4E7C-8948-501F9C7FD0DCQ33646749-2CBCCCEA-03C7-4D2A-B695-BA54DFC64155Q33691958-831CE884-A346-4661-ACCF-7ACD59FC2C29Q33777764-A8D73496-F01A-40D2-9388-10F804A34119Q33793485-8E3CCC1C-1120-4367-A073-903D005476A9Q34095065-53DADCFF-8470-4A42-A306-874995FC42D7Q34183603-633ED753-E6A0-438C-AC77-6F2E17E37E88Q34683465-C31671B5-BE42-49AC-85AB-FBCC9D7F895AQ34759070-297AC764-4084-41F1-BDEE-052E25BC0B3FQ34860664-2852D494-7DAD-4398-9AD1-31E7549256B9Q34903095-DBE48DED-E1E0-4213-A32B-2662A18D5C31Q34905120-F7AE10D0-C491-4956-B969-AFF3039389C7Q34946464-887762B7-068F-4878-BF55-1EF76A4521CFQ34955574-9B2662C0-5450-43FC-A993-33B674B6D211Q34983578-0B666719-9A7C-4300-AA79-BC9838651078Q34984506-EE17C73E-AA69-4F88-811C-4BDAB9FEC52DQ35092662-969671BC-E0C8-409E-88B3-6D90F6BE0EF3Q35118685-45A56B65-3B55-4492-BA70-0254B4FAE54D
P2860
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of interleukin-1 in n ...... ease: an evolving perspective.
@en
The role of interleukin-1 in n ...... ease: an evolving perspective.
@nl
type
label
The role of interleukin-1 in n ...... ease: an evolving perspective.
@en
The role of interleukin-1 in n ...... ease: an evolving perspective.
@nl
prefLabel
The role of interleukin-1 in n ...... ease: an evolving perspective.
@en
The role of interleukin-1 in n ...... ease: an evolving perspective.
@nl
P2093
P2860
P921
P356
P1476
The role of interleukin-1 in n ...... ease: an evolving perspective.
@en
P2093
M Kerry O'Banion
Solomon S Shaftel
W Sue T Griffin
P2860
P2888
P356
10.1186/1742-2094-5-7
P5008
P577
2008-02-26T00:00:00Z
P5875
P6179
1046097877